Atlas Trials

Oral Arsenic Trioxide for NPM1-mutated AML

Clinical trial NCT04689815 · UNKNOWN

Trial details

NCT number
NCT04689815
Sponsor
The University of Hong Kong
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NPMc+ AML
Start date
2021-01-01
Primary completion
2023-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.